Therefore, we propose that the downregulation of BNIP3L is the result of chromosome-pairing induced upregulation of EGLN2 and that downregulation of BNIP3L contributes to the inhibition of apoptosis to facilitate oncocytoma cell survival and growth. The gene discussed is EGLN2; the disease is oncocytic adenoma.